Reset
Id
Protein
PTM type
Site
Species
Disease
Celline
Drug
Regulatory
Confidence score(level)
Ref.
acc2101 KNL1 phosphorylation Thr875 human Breast Cancer MDA-MB-468 Paclitaxel Impairing 5.0 (High) 31575759
acc2102 KNL1 phosphorylation Thr875 human Breast Cancer MDA-MB-231 BOS172722 Associated 4.0 (Moderate) 31575759
acc2103 KNL1 phosphorylation Thr875 human Breast Cancer MDA-MB-468 BOS172722 Associated 4.0 (Moderate) 31575759
acc2104 histone H3 phosphorylation Ser10 human Breast Cancer MDA-MB-231 BOS172722 Associated 3.0 (Low) 31575759
acc2105 histone H3 phosphorylation Ser10 human Breast Cancer MDA-MB-468 BOS172722 Associated 3.0 (Low) 31575759
acc2106 4EBP1 phosphorylation Ser65 human Breast Cancer BT474 Trastuzumab Associated 4.0 (Moderate) 21498638
acc2107 4EBP1 phosphorylation Ser65 human Breast Cancer SK-BR-3 Trastuzumab Associated 4.0 (Moderate) 21498638
acc2108 4EBP1 phosphorylation Ser65 human Colorectal Cancer HCT-8 Cetuximab Associated 4.0 (Moderate) 21498638
acc2109 4EBP1 phosphorylation Ser65 human Colorectal Cancer HCT116 Cetuximab Associated 4.0 (Moderate) 21498638
acc2110 4EBP1 phosphorylation Ser65 human Head and Neck Cancer CAL33 Erlotinib Associated 4.0 (Moderate) 21498638
acc2111 4EBP1 phosphorylation Ser65 human Head and Neck Cancer CAL33-LTE Erlotinib Associated 4.0 (Moderate) 21498638
acc2112 MYC phosphorylation Thr58 human Prostate Cancer PC3 anti-PD1 immunotherapy Enhancing 4.5 (High) 31679823
acc2113 MYC phosphorylation Thr58 human Prostate Cancer MycCaP anti-PD1 immunotherapy Enhancing 4.5 (High) 31679823
acc2114 MYC phosphorylation Thr58 human Prostate Cancer LNCaP anti-PD1 immunotherapy Enhancing 4.5 (High) 31679823
acc2115 STAT3 phosphorylation Ser727 human Lung Cancer A549 Cisplatin Impairing 5.0 (High) 34543857
acc2116 STAT3 phosphorylation Tyr705 human Lung Cancer A549 ACHP Associated 4.0 (Moderate) 31847229
acc2117 STAT3 phosphorylation Tyr705 human Lung Cancer H1299 ACHP Associated 4.0 (Moderate) 31847229
acc2118 STAT3 phosphorylation Tyr705 human Cervical Cancer HeLa Resveratrol Associated 4.0 (Moderate) 33040485
acc2119 STAT3 phosphorylation Tyr705 human Cervical Cancer SiHa Resveratrol Associated 4.0 (Moderate) 33040485
acc2120 p21WAF1/CIP2 phosphorylation Ser146 human Hepatocellular Carcinoma HepG2 Asiatic acid Associated 4.0 (Moderate) 24568526
acc2121 p27 phosphorylation Ser10 human Breast Cancer BT474 Erlotinib Impairing 5.0 (High) 21045138
acc2122 p27 phosphorylation Ser10 human Breast Cancer SK-BR-3 Erlotinib Impairing 5.0 (High) 21045138
acc2123 Cdc2 phosphorylation Tyr15 human Breast Cancer MDA-MB-435 Taxol Impairing 5.0 (High) 12384528
acc2124 Cdc2 phosphorylation Tyr15 human Breast Cancer SK-BR-3 Taxol Impairing 5.0 (High) 12384528
acc2125 Cdc2 phosphorylation Tyr15 human Breast Cancer MDA-MB-453 Taxol Impairing 5.0 (High) 12384528
acc2126 Cdc2 phosphorylation Tyr15 human Breast Cancer 435eB Taxol Impairing 5.0 (High) 12384528
acc2127 p36 phosphorylation unclear mouse Lung Cancer Butylated hydroxytoluene (BHT) Impairing 4.5 (High) 4053047
acc2128 p38 phosphorylation Thr180 human Breast Cancer MCF7 SB203580 Enhancing 5.0 (High) 11060298
acc2129 p38 phosphorylation Thr180 human Leukemia NB-4 SB203580 Enhancing 5.0 (High) 11060298
acc2130 p38 phosphorylation Thr180 human Breast Cancer MCF7 SB202190 Enhancing 5.0 (High) 11060298
acc2131 p38 phosphorylation Thr180 human Leukemia NB-4 SB202190 Enhancing 5.0 (High) 11060298
acc2132 p38 phosphorylation Tyr182 human Breast Cancer MCF7 SB203580 Enhancing 5.0 (High) 11060298
acc2133 p38 phosphorylation Tyr182 human Leukemia NB-4 SB203580 Enhancing 5.0 (High) 11060298
acc2134 p38 phosphorylation Tyr182 human Breast Cancer MCF7 SB202190 Enhancing 5.0 (High) 11060298
acc2135 p38 phosphorylation Tyr182 human Leukemia NB-4 SB202190 Enhancing 5.0 (High) 11060298
acc2136 p38 phosphorylation Thr180 human Colorectal Cancer RKO Melatonin Associated 4.0 (Moderate) 29152648
acc2137 p38 phosphorylation Tyr182 human Colorectal Cancer RKO Melatonin Associated 4.0 (Moderate) 29152648
acc2138 p53 phosphorylation Ser392 human Lung Cancer HCC-827 MX-C4 Associated 4.0 (Moderate) 35902040
acc2139 p53 phosphorylation Ser392 human Lung Cancer HCI-H460 MX-C4 Associated 4.0 (Moderate) 35902040
acc2140 p53 phosphorylation Ser46 human Colorectal Cancer RKO adryamicin Impairing 5.0 (High) 25260780
acc2141 p53 phosphorylation Ser46 human Colorectal Cancer HCT116 adryamicin Impairing 5.0 (High) 25260780
acc2142 p53 phosphorylation Ser46 human Ovarian Cancer 2008 adryamicin Impairing 5.0 (High) 25260780
acc2143 p53 phosphorylation Ser46 human Lung Cancer A549 adryamicin Impairing 5.0 (High) 25260780
acc2144 p53 phosphorylation Ser46 human Colorectal Cancer RKO Cisplatin Impairing 5.0 (High) 25260780
acc2145 p53 phosphorylation Ser46 human Colorectal Cancer HCT116 Cisplatin Impairing 5.0 (High) 25260780
acc2146 p53 phosphorylation Ser46 human Ovarian Cancer 2008 Cisplatin Impairing 5.0 (High) 25260780
acc2147 p53 phosphorylation Ser46 human Lung Cancer A549 Cisplatin Impairing 5.0 (High) 25260780
acc2148 p53 phosphorylation Ser20 human Colorectal Cancer HCT116 Ionising radiation Impairing 4.5 (High) 12384533
acc2149 p53 phosphorylation Ser15 human Colorectal Cancer HCT116 NO + ionizing radiation Enhancing 4.5 (High) 15520210
acc2150 p53 phosphorylation Ser15 human Gastric Cancer SNU-1040 NO + ionizing radiation Enhancing 4.5 (High) 15520210